Receptor use by the Whitewater Arroyo virus glycoprotein.

PubWeight™: 0.93‹?›

🔗 View Article (PMC 2270610)

Published in Virology on November 13, 2007

Authors

Therese Reignier1, Jill Oldenburg, Meg L Flanagan, Genevieve A Hamilton, Vanessa K Martin, Paula M Cannon

Author Affiliations

1: Saban Research Institute of Childrens Hospital Los Angeles, Los Angeles, CA, USA.

Articles cited by this

Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (1991) 38.64

Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science (1998) 5.83

Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med (2006) 5.42

A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis (1987) 5.27

Exotic emerging viral diseases: progress and challenges. Nat Med (2004) 4.54

Functional expression of the human transferrin receptor cDNA in Chinese hamster ovary cells deficient in endogenous transferrin receptor. J Cell Biol (1987) 3.28

Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature (2007) 3.06

Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum Mol Genet (1997) 2.69

Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol Phylogenet Evol (1997) 2.36

New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor. J Virol (2002) 2.35

Posttranslational modification of alpha-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding. J Virol (2005) 2.17

The phylogeny of New World (Tacaribe complex) arenaviruses. Virology (1996) 2.11

Tamiami virus, a new member of the TaCaribe group. Am J Trop Med Hyg (1970) 1.99

Congenital lymphocytic choriomeningitis virus infection: spectrum of disease. Ann Neurol (2007) 1.98

Isolation and characterization of Whitewater Arroyo virus, a novel North American arenavirus. Virology (1996) 1.87

Arenaviruses other than Lassa virus. Antiviral Res (2003) 1.86

Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics. J Virol (2001) 1.85

New world clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and -independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1. J Virol (2007) 1.69

Phylogeny of New World arenaviruses based on the complete coding sequences of the small genomic segment identified an evolutionary lineage produced by intrasegmental recombination. Biochem Biophys Res Commun (2002) 1.45

Tamiami virus in the Tampa Bay area. Am J Trop Med Hyg (1970) 1.42

High genetic divergence and recombination in Arenaviruses from the Americas. Virology (2002) 1.37

Characterization of the cellular receptors for the South American hemorrhagic fever viruses Junin, Guanarito, and Machupo. Virology (2006) 1.36

Arenavirus antibody in rodents indigenous to coastal southern California. Am J Trop Med Hyg (2000) 1.33

Principal host relationships and evolutionary history of the North American arenaviruses. Virology (2007) 1.32

Tacaribe virus, a new agent isolated from Artibeus bats and mosquitoes in Trinidad, West Indies. Am J Trop Med Hyg (1963) 1.27

Receptor use by pathogenic arenaviruses. Virology (2006) 1.27

Fatal illnesses associated with a new world arenavirus--California, 1999-2000. MMWR Morb Mortal Wkly Rep (2000) 1.27

Receptor structure, binding, and cell entry of arenaviruses. Curr Top Microbiol Immunol (2002) 1.21

Bear Canyon virus: an arenavirus naturally associated with the California mouse (Peromyscus californicus). Emerg Infect Dis (2002) 1.15

Hantavirus and arenavirus antibodies in persons with occupational rodent exposure. Emerg Infect Dis (2007) 1.13

Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus. Virology (2004) 1.11

Lymphocytic choriomeningitis virus: an emerging obstetric pathogen? Am J Obstet Gynecol (2006) 1.11

The Whitewater Arroyo virus: natural evidence for genetic recombination among Tacaribe serocomplex viruses (family Arenaviridae). Virology (2001) 1.08

New insights into the evolutionary relationships between arenaviruses provided by comparative analysis of small and large segment sequences. Virology (2003) 1.07

Differences in tropism and pH dependence for glycoproteins from the Clade B1 arenaviruses: implications for receptor usage and pathogenicity. Virology (2007) 1.04

Hydrocephalus due to prenatal infection with the lymphocytic choriomeningitis virus. Infection (1976) 0.96

Emerging diseases. New arenavirus blamed for recent deaths in California. Science (2000) 0.80

Articles by these authors

Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol (2010) 6.55

Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production. J Virol (2005) 1.97

HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment. Retrovirology (2010) 1.87

New world clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and -independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1. J Virol (2007) 1.69

Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Nat Genet (2002) 1.67

Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases. Mol Ther (2013) 1.49

Cytoplasmic tail of Moloney murine leukemia virus envelope protein influences the conformation of the extracellular domain: implications for mechanism of action of the R Peptide. J Virol (2003) 1.48

Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal. J Virol (2010) 1.47

Anti-tetherin activities in Vpu-expressing primate lentiviruses. Retrovirology (2010) 1.40

Receptor use by pathogenic arenaviruses. Virology (2006) 1.27

Lack of adaptation to human tetherin in HIV-1 group O and P. Retrovirology (2011) 1.14

Recruitment of the adaptor protein 2 complex by the human immunodeficiency virus type 2 envelope protein is necessary for high levels of virus release. J Virol (2006) 1.12

Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system. Hum Gene Ther (2009) 1.08

Differences in tropism and pH dependence for glycoproteins from the Clade B1 arenaviruses: implications for receptor usage and pathogenicity. Virology (2007) 1.04

Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts. J Virol (2012) 1.02

Substitutions in the glycoprotein (GP) of the Candid#1 vaccine strain of Junin virus increase dependence on human transferrin receptor 1 for entry and destabilize the metastable conformation of GP. J Virol (2011) 1.00

Pre-clinical modeling of CCR5 knockout in human hematopoietic stem cells by zinc finger nucleases using humanized mice. J Infect Dis (2013) 0.97

Targeted and untargeted CD137L fusion proteins for the immunotherapy of experimental solid tumors. Clin Cancer Res (2007) 0.90

Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potential. Hum Gene Ther (2007) 0.89

Investigation of clade B New World arenavirus tropism by using chimeric GP1 proteins. J Virol (2009) 0.86

Vpu-dependent block to incorporation of GaLV Env into lentiviral vectors. Retrovirology (2010) 0.85

Use of pseudotyped retroviral vectors to analyze the receptor-binding pocket of hemagglutinin from a pathogenic avian influenza A virus (H7 subtype). Virus Res (2002) 0.85

Pseudotyping incompatibility between HIV-1 and gibbon ape leukemia virus Env is modulated by Vpu. J Virol (2009) 0.84

RA8, a human anti-CD25 antibody against human Treg cells. Hybridoma (Larchmt) (2007) 0.78

A systems biology starter kit for arenaviruses. Viruses (2012) 0.75